1. Complete response of stage IV pancreatic cancer combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range hyperthermia. (March 2019) Authors: Kleef, R.; Nagy, R.; Bohdjalian, A.; Bacher, V.; Wychera, A.; Kekic, S.; McKee, D.; Bojar, H.; Moss, R. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗